Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Kidney and Transplant

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 50%Moderate 1 · 50%High 0 · 0%

Death at 6 months · adults with renal vasculitis

Rituximab showed no clear difference in death at 6 months compared with cyclophosphamide (moderate certainty).

1 finding from 1 review

Interventions for renal vasculitis in adults 2020 · Cochrane Headline outcomes only
RR 1 [0.21, 4.7]
2 studies · 241 participants
Moderate

Death at 6 months · adults with renal vasculitis

Mycophenolate mofetil showed no clear difference in death at 6 months compared with cyclophosphamide (low certainty).

1 finding from 1 review

Interventions for renal vasculitis in adults 2020 · Cochrane Headline outcomes only
RR 1.25 [0.35, 4.46]
1 study · 140 participants
Low